Loading asset research
Theravance Biopharma Inc. Ordinary Shares
TBPHNasdaq · USD · StocksQuote as of · Exchange session not verified$17.02
-0.00%
Today
TBPH
Loading 1D prices…
Market cap
$883.1M
Volume
426.8K
52w high
$21.0352w low
$13.08Company profile
Theravance Biopharma Inc. Ordinary Shares
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
South San Francisco, CA, United States
Employees
90
Fiscal year end
1231
CIK
1583107
Session & valuation
Open$17.06
Previous close$17.02
Day high$17.06
Day low$17.00
30-day avg. volume480.7K
Outstanding shares51.9M
Diluted EPS$2.06
Latest annual period
P/E (trailing)16.36
P/E (forward)13.34
Price / book3.05
Beta0.24
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RIGLRigel Pharmaceuticals Inc. Common Stock | $882.4M | $294.3M | +124.72% | $19.48 | -0.08% | Buy |
| LXRXLexicon Pharmaceuticals Inc. Common Stock | $889.9M | $49.8M | -101.08% | -$0.14 | -1.24% | Buy |
| OLMAOlema Pharmaceuticals Inc. Common Stock | $894.2M | $0.00 | — | -$1.87 | -4.30% | Buy |
| IMMXImmix Biopharma Inc. Common Stock | $868.5M | $0.00 | — | -$0.89 | -4.49% | Buy |
| GERNGeron Corporation Common Stock | $867.3M | $183.9M | -45.41% | -$0.13 | -1.82% | Hold |